Archives: Media Coverage

FDA Watch Podcast: FDA’s 2026 Food Priorities
Listen to the podcast: https://fdawatch.net/2026/02/09/fdas-2026-food-priorities/ Summary Wayne chats with David Lennarz, President of Registrar Corp., and Dr. Susan Mayne, Adjunct Professor at the Yale School of Public Health and former Director of FDA’s Center for Food Safety and Applied Nutrition. You’ll hear their thoughts on the Human Foods Program’s 2026 priority deliverables; how the new
Read more »
2026 Year of ‘Clarity’ for US Beauty?
Read full article here: https://insights.citeline.com/hbw-insight/beauty/business/2026-year-of-clarity-for-us-beauty-regulatory-reform-fda-enforcement-strategy-coming-into-focus-KQ5HVJ47YBE4LOJDLHRHLCRDEU/ SummaryThis roundup of experts on cosmetic industry, including David Lennarz, President of Registrar Corp, investigates upcoming regulatory reform, FDA enforcement strategy, and the impact AI will have on innovation, data systems, and supply chains.
Read more »
Registrar Corp Acquires TechniCAL and Becomes the Global Compliance Leader in Shelf-stable Packaged Foods Safety
Registrar Corp Becomes the Global Compliance Leader in Shelf-stable Packaged Foods Safety
Read more »
Rates, Raw Materials, and Risk: Economic Considerations for Food Manufacturers in 2026
This article argues that 2026 will be a year of managed uncertainty rather than crisis or boom for food manufacturers. Interest rates are expected to ease somewhat but remain structurally higher than the pre-COVID era, meaning capital will still require discipline and strong justification. Raw material costs may stabilize or soften in some categories, but
Read more »
FDA’s FSMA 204 Rule Change. Now What?
Read full article here: https://www.foodlogistics.com/safety-security/food-safety/article/22957035/registrar-corp-fdas-fsma-204-rule-change-now-what Summary:The FDA has extended the compliance deadline for the FSMA 204 food traceability rule by 30 months, moving it from January 2026 to July 2028 to give the food industry more time to build interoperable supply-chain systems. However, the rule’s core requirements remain unchanged: companies handling certain high-risk foods must
Read more »
Registrar Corp Acquires CMC Medical Devices to Make Global Compliance Quick and Easy
[MALAGA, Spain & HAMPTON, Va., November 13, 2025] — (BUSINESS WIRE) — Registrar Corp, a global leader in regulatory compliance and technology solutions and a Paine Schwartz Partners portfolio company, today announced the acquisition of CMC Medical Devices (CMC), a Spain-based provider of medical device regulatory, clinical, and compliance consulting services. The combination of Registrar Corp’s
Read more »
The Cost of FSVP Non-Compliance
The Foreign Supplier Verification Program (FSVP) is a cornerstone of the FDA’s Food Safety Modernization Act (FSMA), designed to uphold the safety of imported food products. This trade publication delves into the significant implications of FSVP non-compliance, from financial and reputational risks to operational disruptions. It also highlights common pitfalls businesses face when navigating the
Read more »
FSVP’s Impact on Canadian Suppliers
This trade publication covers the Foreign Supplier Verification Program (FSVP) – a key regulation under the FDA’s Food Safety Modernization Act (FSMA). It breaks down what US importers must do to verify their foreign suppliers are meeting FDA food safety standards, including risk based activities such as hazard analysis, supplier evaluations, verification processes and corrective
Read more »
Registrar Corp Acquires Personal Care Regulatory (PCR), Expanding Global Cosmetic Regulatory Compliance Services
[Cambridge, UK and Hampton, VA, December 9, 2024] – Registrar Corp, the world’s largest cosmetics compliance company, is pleased to announce its acquisition of Personal Care Regulatory (PCR) Group, a leading cosmetic regulatory, toxicology, and compliance company based in the United Kingdom (UK) and Ireland. This strategic acquisition extends Registrar’s global regulatory compliance capabilities. The
Read more »
Top US Retailers Selling Non-FDA Compliant Cosmetics
A US Food and Drug Administration (FDA) compliance company is sounding the alarm over high non-compliance rates with new FDA cosmetics regulations. Registrar Corp’s assessment indicates that 48% of cosmetics companies importing to the top 25 US retailers are not FDA compliant and could risk removal from stores. Read the original article here. Registrar Corp,
Read more »
Cosmetic Industry Faces Significant Non-Compliance Under New FDA Regulations
Discover why 48% of companies selling imported cosmetics at America’s top 25 retailers are non-compliant with MoCRA.
Read more »
FDA Implements New Rules to Govern Cosmetics
The federal government has introduced new regulations to improve the safety of cosmetic products, marking the most significant FDA updates on cosmetics in 85 years. These changes focus on three key areas: professional-use products, adverse event reporting labels, and fragrance allergen labeling. First, makeup products intended for professional use now require clear labeling to indicate
Read more »
New FDA Rules Change the Way Cosmetic Brands Do Business
The FDA’s Modernization of Cosmetics Regulation Act introduces new requirements for the cosmetics industry, significantly increasing regulation for the first time since 1938. Key changes include: Facility Registration: Companies must register their manufacturing facilities with the FDA. Product Listings: All marketed cosmetic products, including their ingredients, must be listed and updated with the FDA. Adverse
Read more »Regulations In Place to Make Cosmetics Safer
New scrutiny from the U.S. Food and Drug Administration (FDA) aims to make cosmetics safer, officials said. On July 1, companies that make products like makeup, shampoo, skincare, artificial eyelashes, tattoo ink, mouthwash, hair dyes, sunless tanning lotions, and waxing kits began adhering to strict FDA regulations, the first of which in over 85 years.
Read more »AEM Streamlines Adverse Event Reporting Process
Registrar Corp. has introduced an Adverse Event Management (AEM) software in response to the FDA’s Modernization of Cosmetics Regulation Act (MoCRA). This new regulation mandates that cosmetic brands include contact information on both primary and secondary packaging for reporting adverse events. The software provides companies with a brand-specific URL or QR code, enabling consumers to
Read more »
How MoCRA Compliance & AEM Software Transforms Reporting
The article focuses on the impact of the Modernization of Cosmetics Regulation Act (MoCRA) on the cosmetics industry, emphasizing the shift toward improved adverse event reporting and our new AEM Software. The new regulation, which came into effect at the end of 2023, requires cosmetic companies to enhance transparency by listing contact information on packaging
Read more »Introducing AEM: A MoCRA-Assist Software Package
Introducing AEM, (Adverse Event Management software), a first-of-its-kind platform designed to help cosmetics companies comply with the FDA’s Modernization of Cosmetics Regulation Act (MoCRA). The software securely collects sensitive data, tracks adverse events globally, and formats serious cases for FDA submission in the MedWatch format. MoCRA’s complex reporting requires coordination across various departments, including compliance,
Read more »Cosmetic Industry Not Prepared For New Adverse Event Rules
Registrar Corp has introduced its Adverse Event Management (AEM) software to aid the cosmetic industry in complying with the FDA’s Modernization of Cosmetics Regulation Act (MoCRA). MoCRA introduces stricter requirements for cosmetic product safety, including displaying contact information on packaging, collecting consumer medical data, and reporting serious adverse events to the FDA within 15 days.
Read more »Meeting 5 MoCRA Mandates for Adverse Event Reporting
Registrar Corp has launched its Adverse Event Management (AEM) software to assist cosmetics companies in meeting the FDA’s new requirements MoCRA mandates. These mandates include displaying contact information on packaging, collecting detailed consumer medical data, investigating adverse events, reporting serious cases to the FDA within 15 days, and maintaining records for up to six years.
Read more »

